 TEL AVIV, Israel and RALEIGH, NC, June 21, 2021 PRNewswire -- RedHill Biopharma Ltd. Nasdaq: RDHL RedHill or the Company, a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib Yeliva, ABC2946401 in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum WMF 2021 poster : 5574. 